pillbase.ru

Ebglyss

Active substance: lebrikizumab

Lebrikizumab

Centralised EU authorisationActive

Marketing holder: Almirall, S.A.

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 2
  • EBGLYSS
    INJECTION, SOLUTION · LEBRIKIZUMAB 250 mg/2mL
    0002-7772
    Eli Lilly and Company
  • EBGLYSS
    INJECTION, SOLUTION · LEBRIKIZUMAB 250 mg/2mL
    0002-7797
    Eli Lilly and Company
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a12091-6792-78d2-8ad3-dde7c0f59b5d,01a12095-663f-7edc-9127-54b4006a0928;count=2 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/005894
Registration status
Active
ATC code
D11AH10
Sources
  • product · EMA · EMEA/H/C/005894 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/005894 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/005894 · Verified 2026-10-09